DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Green, M. D.
Right arrow Articles by Tephly, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Green, M. D.
Right arrow Articles by Tephly, T. R.

Vol. 25, Issue 12, 1389-1394, 1997

Glucuronidation of Opioids, Carboxylic Acid-Containing Drugs, and Hydroxylated Xenobiotics Catalyzed by Expressed Monkey UDP-Glucuronosyltransferase 2B9 Protein

Mitchell D. Green, Guy Bélanger, Dean W. Hum, Alain Bélanger, and Thomas R. Tephly

Department of Pharmacology, The University of Iowa (M.D.G., T.R.T.), and Centre de Recherches en Endocrinologie Moléculaire, Le Centre Hospitalier de l'Université Laval (G.B., D.W.H., A.B.)

UDP-glucuronosyltransferase (UGT) 2B9, isolated from a cynomolgus monkey liver cDNA library, is 89% identical to human UGT2B7 in primary amino acid sequence, and the two expressed enzymes were previously shown to catalyze the glucuronidation of many common endogenous substrates. The purpose of the present study was to characterize the reactivity of expressed UGT2B9 with important therapeutic agents and other xenobiotics. UGT2B9, stably expressed in human embryonic kidney 293 cells, catalyzes the 3-O- and 6-O-glucuronidation of morphine and the 6-O-glucuronidation of codeine. A number of other morphinan (e.g. naloxone, naltrexone, and nalorphine) and oripavine (e.g. buprenorphine) derivatives are substrates for this enzyme. In general, morphinan derivatives are glucuronidated at higher rates, compared with oripavines; however, glucuronidation efficiency values (Vmax/KM) for the compounds are similar. Stably expressed UGT2B9 also catalyzes the glucuronidation of profen nonsteroidal anti-inflammatory drugs, fibrate hypolipidemic agents, and straight-chain fatty acids at the carboxylic acid moiety. Monoterpenoid alcohols and propanolol are glucuronidated at aliphatic hydroxyl positions. Expressed UGT2B9 exhibits enantioselective glucuronidation for (R/S)-ibuprofen, (R/S)-propanolol, and (+)/(-)-menthol. The data suggest that monkey UGT2B9 and human UGT2B7 are functionally similar.

Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 ChestHome page
A. J. Alberg, J. G. Ford, and J. M. Samet
Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 29S - 55S.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. Kaji and T. Kume
REGIOSELECTIVE GLUCURONIDATION OF DENOPAMINE: MARKED SPECIES DIFFERENCES AND IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ISOFORM
Drug Metab. Dispos., March 1, 2005; 33(3): 403 - 412.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
L. V. Iyer, M. N. Ho, W. M. Shinn, W. W. Bradford, M. J. Tanga, S. S. Nath, and C. E. Green
Glucuronidation of 1'-Hydroxyestragole (1'-HE) by Human UDP-Glucuronosyltransferases UGT2B7 and UGT1A9
Toxicol. Sci., May 1, 2003; 73(1): 36 - 43.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
B. L. Coffman, W. R. Kearney, S. Goldsmith, B. M. Knosp, and T. R. Tephly
Opioids Bind to the Amino Acids 84 to 118 of UDP-Glucuronosyltransferase UGT2B7
Mol. Pharmacol., February 1, 2003; 63(2): 283 - 288.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Y. Ishii, A. Miyoshi, R. Watanabe, K. Tsuruda, M. Tsuda, Y. Yamaguchi-Nagamatsu, K. Yoshisue, M. Tanaka, D. Maji, S. Ohgiya, et al.
Simultaneous Expression of Guinea Pig UDP-Glucuronosyltransferase 2B21 and 2B22 in COS-7 Cells enhances UDP-Glucuronosyltransferase 2B21-Catalyzed Morphine-6-Glucuronide Formation
Mol. Pharmacol., November 1, 2001; 60(5): 1040 - 1048.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
B. L. Coffman, W. R. Kearney, M. D. Green, R. G. Lowery, and T. R. Tephly
Analysis of Opioid Binding to UDP-Glucuronosyltransferase 2B7 Fusion Proteins Using Nuclear Magnetic Resonance Spectroscopy
Mol. Pharmacol., June 1, 2001; 59(6): 1464 - 1469.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
C. King, B. Finley, and R. Franklin
The Glucuronidation of Morphine by Dog Liver Microsomes: Identification of Morphine-6-O-Glucuronide
Drug Metab. Dispos., June 1, 2000; 28(6): 661 - 663.
[Abstract] [Full Text]

Home page
 JAMAHome page
E. M. Sellers
Pharmacogenetics and Ethnoracial Differences in Smoking
JAMA, July 8, 1998; 280(2): 179 - 180.
[Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.